DeepMed Research

McKenzie, Dr Leanne S Md

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.childrenshospital.ab.ca/about-us/our-partners/alberta-heath-services

Clinical Trials

An Evaluation of Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision

Phase 2

Completed

Conditions: Pain, Postoperative
Phimosis
Balanitis
Paraphimosis

Interventions: Drug: Bupivacain
Drug: Sevoflurane
Drug: Acetaminophen
Drug: Ibuprofen
Drug: Ketorolac

First Posted Date: 2020-11-30

Last Posted Date: 2024-08-02

Lead Sponsor: Alberta Children's Hospital

Target Recruit Count: 100

Registration Number: NCT04646967

Locations: 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada

Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Hernia Repair

Not Applicable

Conditions: Hernia, Inguinal
Pain, Postoperative

Interventions: Procedure: Caudal-epidural nerve block
Procedure: Ilioinguinal/iliohypogastric nerve block
Drug: Acetaminophen
Drug: Sevoflurane
Drug: Remifentanil
Drug: Propofol
Drug: Morphine
Drug: Ondansetron
Drug: Dexamethasone
Drug: Ketorolac

First Posted Date: 2017-02-03

Last Posted Date: 2017-11-14

Lead Sponsor: Alberta Children's Hospital

Target Recruit Count: 88

Registration Number: NCT03041948

Locations: 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada
🇨🇦
Royal University Hospital/University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Orchiopexy Repair

Not Applicable

Completed

Conditions: Pain, Postoperative
Testicle Undescended

Interventions: Procedure: Caudal-epidural nerve block
Procedure: Ilioinguinal/iliohypogastric nerve block
Drug: Acetaminophen
Drug: Sevoflurane
Drug: Remifentanil
Drug: Propofol
Drug: Morphine
Drug: Ondansetron
Drug: Dexamethasone
Drug: Ketorolac
Drug: Ropivacaine

First Posted Date: 2017-02-03

Last Posted Date: 2022-02-16

Lead Sponsor: Alberta Children's Hospital

Target Recruit Count: 90

Registration Number: NCT03041935

Locations: 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada

Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision

Phase 1

Completed

Conditions: Pain, Postoperative
Phimosis
Paraphimosis
Balanitis

Interventions: Drug: Bupivacaine
Drug: Sevoflurane
Drug: Acetaminophen
Drug: Ibuprofen
Drug: Ketorolac

First Posted Date: 2016-11-28

Last Posted Date: 2018-06-29

Lead Sponsor: Alberta Children's Hospital

Target Recruit Count: 30

Registration Number: NCT02973958

Locations: 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada

Improving CPR Quality With Longitudinal Practice and Realtime Feedback - RCT With CEA

Not Applicable

Conditions: Cardiopulmonary Resuscitation

Interventions: Other: Longitudinal practice and real-time feedback

First Posted Date: 2015-09-03

Last Posted Date: 2015-09-03

Lead Sponsor: Alberta Children's Hospital

Target Recruit Count: 110

Registration Number: NCT02539238

Locations: 🇨🇦
Alberta Children's Hospital/KidSIM simulation center, Calgary, Alberta, Canada

Antimicrobial Stewardship in Pediatric Surgery

Withdrawn

Conditions: Appendicitis

Interventions: Other: Antimicrobial Stewardship Program

First Posted Date: 2014-10-22

Last Posted Date: 2018-03-20

Lead Sponsor: Alberta Children's Hospital

Registration Number: NCT02270996

RCT Gum Chewing on Bowel Function After Abdominal Surgery in Children

Not Applicable

Withdrawn

Conditions: Postoperative Ileus

Interventions: Other: Gum chewing

First Posted Date: 2014-10-10

Last Posted Date: 2018-03-20

Lead Sponsor: Alberta Children's Hospital

Registration Number: NCT02261454

Locations: 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada

Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure

Phase 1

Terminated

Conditions: Intestinal Failure
Short Bowel Syndrome

Interventions: Drug: Glucagon-Like Peptide 2
Drug: Glucagon like peptide-2

First Posted Date: 2012-04-09

Last Posted Date: 2014-12-23

Lead Sponsor: Alberta Children's Hospital

Target Recruit Count: 13

Registration Number: NCT01573286

Locations: 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada
🇨🇦
British Columbia Children's Hospital, Vancouver, British Columbia, Canada
🇨🇦
Stollery Children's Hospital, Edmonton, Alberta, Canada

and more 1 locations

Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients

Phase 3

Terminated

Conditions: Childhood Cancer
Aplastic Anemia
Metabolic Disorders

Interventions: Drug: Heparin
Drug: Normal saline

First Posted Date: 2011-04-28

Last Posted Date: 2012-05-30

Lead Sponsor: Alberta Children's Hospital

Target Recruit Count: 2

Registration Number: NCT01343680

Locations: 🇨🇦
Stollery Children's Hospital, Edmonton, Alberta, Canada
🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada

Comparison of Casting Materials for the Treatment of Clubfoot Using the Ponseti Method

Not Applicable

Completed

Conditions: Clubfoot
Ponseti Method
Talipes Equinovarus
Casting

Interventions: Device: Plaster of Paris (POP) casting using the Ponseti Method
Device: Semi-Rigid Fiberglass softcast using the Ponseti Method

First Posted Date: 2010-02-11

Last Posted Date: 2010-02-11

Lead Sponsor: Alberta Children's Hospital

Target Recruit Count: 30

Registration Number: NCT01067651

Locations: 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy